🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial studies how well new magnetic resonance imaging (MRI) and magnet...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-04-16
Trial ID
NCT03980535
Treatments Being Tested
This randomized phase II-R/III trial studies gemcitabine hydrochloride with...
Status
Completed
Location
Providence Hospital
Start Date
2010-04-05
Trial ID
NCT01013649
This phase II trial tests how well fluorouracil, oxaliplatin and leucovorin...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-05-20
Trial ID
NCT06780787
This study is to investigate how adipocyte (fat cell) function and fat dist...
Status
Recruiting
Location
Stanford University
Start Date
2025-01-13
Trial ID
NCT06657209
Treatments Being Tested
To investigate the glutaminergic system in the onset of migraine-like attac...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT04220606
Treatments Being Tested
This research study will be conducted in patients with primary autonomic fa...
Status
Terminated
Location
Vanderbilt University
Start Date
2012-07
Trial ID
NCT01607268
Treatments Being Tested
Non-alcoholic fatty liver disease (NAFLD) is a common human liver pathology...
Status
Unknown
Location
Medical University Of Vienna, Department of Internal Medicine III
Start Date
2014-09
Trial ID
NCT02164032
This phase I/IIa trial tests the safety, side effects, and best dose of che...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2024-02-16
Trial ID
NCT05756166
This phase III trial studies how well pressurized intraperitoneal aerosoliz...
Status
Not Yet Recruiting
Location
CTCA at Western Regional Medical Center
Start Date
2026-10-01
Trial ID
NCT07271355
This phase I trial tests the safety, side effects, and best dose of intrape...
Status
Active Not Recruiting
Location
Ohio State University Comprehensive Cancer Center
Start Date
2024-12-31
Trial ID
NCT06269978